Related Experiment Videos

Disposition of vancomycin during hemofiltration

Insights

Hemofiltration significantly alters vancomycin levels, drastically reducing its half-life (t 1/2) during treatment. Post-hemofiltration, vancomycin serum concentrations rebound, necessitating personalized dosing strategies for this antibiotic.

Area of Science:

  • Pharmacokinetics and Pharmacodynamics
  • Nephrology and Critical Care Medicine
  • Infectious Disease Management

Background:

  • Vancomycin is a critical antibiotic for treating serious Gram-positive infections.
  • Hemofiltration is used in critically ill patients to manage fluid and electrolyte balance.
  • The impact of hemofiltration on vancomycin disposition in patients is not well-established.

Purpose of the Study:

  • To investigate the pharmacokinetic changes of vancomycin during hemofiltration.
  • To quantify vancomycin removal and clearance during hemofiltration.
  • To assess the post-hemofiltration rebound effect on vancomycin serum concentrations.

Main Methods:

  • Five patients receiving intravenous vancomycin underwent pharmacokinetic profiling.
  • Serum vancomycin concentrations were measured before, during, and after hemofiltration.
  • Vancomycin clearance and ultrafiltration rates were correlated.

Main Results:

  • Vancomycin's elimination half-life (t 1/2) decreased from 136.0 hours to 4.1 hours during hemofiltration.
  • Hemofiltration clearance of vancomycin was 152.6 ml/min, with approximately 400 mg removed.
  • A significant rebound in vancomycin serum concentration (52.4%) was observed post-hemofiltration.

Conclusions:

  • Hemofiltration significantly impacts vancomycin disposition, increasing its clearance and reducing its half-life.
  • The observed rebound effect and interpatient variability necessitate individualized vancomycin dosing.
  • Adjusted vancomycin dosing regimens are crucial for patients undergoing hemofiltration to ensure therapeutic efficacy.

Related Concept Videos